JP2010506826A5 - - Google Patents

Download PDF

Info

Publication number
JP2010506826A5
JP2010506826A5 JP2009516776A JP2009516776A JP2010506826A5 JP 2010506826 A5 JP2010506826 A5 JP 2010506826A5 JP 2009516776 A JP2009516776 A JP 2009516776A JP 2009516776 A JP2009516776 A JP 2009516776A JP 2010506826 A5 JP2010506826 A5 JP 2010506826A5
Authority
JP
Japan
Prior art keywords
peptide
cancer
cell
hla
antigen
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2009516776A
Other languages
English (en)
Japanese (ja)
Other versions
JP2010506826A (ja
JP5339292B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/JP2007/001122 external-priority patent/WO2008047473A1/en
Publication of JP2010506826A publication Critical patent/JP2010506826A/ja
Publication of JP2010506826A5 publication Critical patent/JP2010506826A5/ja
Application granted granted Critical
Publication of JP5339292B2 publication Critical patent/JP5339292B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2009516776A 2006-10-17 2007-10-16 Mphosph1またはdepdc1ポリペプチドを発現する癌に対するペプチドワクチン Active JP5339292B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US85257506P 2006-10-17 2006-10-17
US60/852,575 2006-10-17
PCT/JP2007/001122 WO2008047473A1 (en) 2006-10-17 2007-10-16 Peptide vaccines for cancers expressing mphosph1 or depdc1 polypeptides

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2013006870A Division JP2013116115A (ja) 2006-10-17 2013-01-18 Mphosph1またはdepdc1ポリペプチドを発現する癌に対するペプチドワクチン

Publications (3)

Publication Number Publication Date
JP2010506826A JP2010506826A (ja) 2010-03-04
JP2010506826A5 true JP2010506826A5 (https=) 2010-12-02
JP5339292B2 JP5339292B2 (ja) 2013-11-13

Family

ID=39313729

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2009516776A Active JP5339292B2 (ja) 2006-10-17 2007-10-16 Mphosph1またはdepdc1ポリペプチドを発現する癌に対するペプチドワクチン
JP2013006870A Pending JP2013116115A (ja) 2006-10-17 2013-01-18 Mphosph1またはdepdc1ポリペプチドを発現する癌に対するペプチドワクチン

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2013006870A Pending JP2013116115A (ja) 2006-10-17 2013-01-18 Mphosph1またはdepdc1ポリペプチドを発現する癌に対するペプチドワクチン

Country Status (17)

Country Link
US (5) US8557955B2 (https=)
EP (7) EP2476698B1 (https=)
JP (2) JP5339292B2 (https=)
KR (4) KR101543622B1 (https=)
CN (5) CN102850433B (https=)
AU (1) AU2007311395B2 (https=)
BR (1) BRPI0717651A2 (https=)
CA (2) CA2915560A1 (https=)
DK (1) DK2091965T3 (https=)
ES (4) ES2545457T3 (https=)
IL (4) IL198186A (https=)
MX (1) MX2009004147A (https=)
PL (1) PL2091965T3 (https=)
PT (1) PT2091965E (https=)
RU (1) RU2469044C2 (https=)
SG (2) SG175566A1 (https=)
WO (1) WO2008047473A1 (https=)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101175862A (zh) 2005-02-10 2008-05-07 肿瘤疗法科学股份有限公司 诊断膀胱癌的方法
CN101827936B (zh) * 2007-08-20 2014-12-10 肿瘤疗法科学股份有限公司 Cdh3肽以及含有cdh3肽的药剂
US8975086B2 (en) 2008-08-28 2015-03-10 Oncotherapy Science, Inc. Method for treating or preventing bladder cancer using the DEPDC1 polypeptide
BRPI1012312A2 (pt) * 2009-03-04 2017-03-21 Oncotherapy Science Inc peptídeos vangl1 e vacinas incluindo os mesmos
TW201211250A (en) * 2010-09-07 2012-03-16 Oncotherapy Science Inc VANGL1 peptides and vaccines including the same
JP5564730B2 (ja) * 2011-08-12 2014-08-06 オンコセラピー・サイエンス株式会社 Mphosph1ペプチドおよびそれを含むワクチン
JP2013058294A (ja) * 2011-09-09 2013-03-28 Toshiba Corp 磁気記録媒体及び磁気記録媒体の製造方法
ES3011307T3 (en) 2012-02-23 2025-04-07 Juno Therapeutics Gmbh Chromatographic isolation of cells and other complex biological materials
US20150359864A1 (en) 2012-03-09 2015-12-17 Oncotherapy Science, Inc. Pharmaceutical composition containing peptides
JP6041297B2 (ja) * 2012-08-24 2016-12-07 国立大学法人山口大学 犬リンパ腫の診断方法及び診断キット
MY177482A (en) * 2013-03-13 2020-09-16 Zhong Li Microvesicle and method for producing the same
SI3132247T1 (sl) 2014-04-16 2021-12-31 Juno Therapeutics Gmbh Postopki, kompleti in naprava za povečanje populacije celic
EP3925968A3 (en) 2014-10-07 2022-03-02 Cytlimic Inc. Hsp70-derived peptide, pharmaceutical composition for treating or preventing cancer using same, immunity inducer, and method for producing antigen-presenting cell
JP6781508B2 (ja) * 2014-11-18 2020-11-04 塩野義製薬株式会社 安定化されたペプチド組成物
CN113388021A (zh) 2015-03-09 2021-09-14 Cytlimic公司 源于gpc3的肽、使用其的医药组合物、免疫诱导剂、及抗原呈递细胞的制造方法
RU2709015C2 (ru) 2015-04-07 2019-12-13 Ситлимик Инк. Лекарственное средство
CA2994929A1 (en) * 2015-08-12 2017-02-16 Oncotherapy Science, Inc. Depdc1-derived peptide and vaccine containing same
SG11201802286PA (en) 2015-10-08 2018-04-27 Oncotherapy Science Inc Mphosph1-derived peptide, and vaccine including same
MX2018004875A (es) 2015-10-22 2018-08-01 Juno Therapeutics Gmbh Metodos para cultivar celulas y kits y aparatos para ello.
EP3365453A2 (en) 2015-10-22 2018-08-29 Juno Therapeutics GmbH Methods, kits, agents and apparatuses for transduction
AU2016341529B2 (en) 2015-10-22 2023-03-30 Juno Therapeutics Gmbh Methods for culturing cells and kits and apparatus for same
US11291718B2 (en) 2016-10-11 2022-04-05 Cytlimic Inc. Method for treating cancer by administering a toll-like receptor agonist and LAG-3 IgG fusion protein
TW201831503A (zh) * 2016-11-18 2018-09-01 日商腫瘤療法 科學股份有限公司 對於th1細胞的mphosph1抗原決定位胜肽及包含其之疫苗
TW201831502A (zh) * 2016-11-18 2018-09-01 日商腫瘤療法 科學股份有限公司 對於th1細胞的depdc1抗原決定位胜肽及包含其之疫苗
WO2018094569A1 (zh) * 2016-11-22 2018-05-31 深圳华大基因研究院 多肽及其应用
PL4029494T3 (pl) 2017-01-25 2026-03-23 Ose Immunotherapeutics Sposób wytwarzania stabilnej emulsji do dostarczania peptydów
JP7339160B2 (ja) 2017-04-27 2023-09-05 ジュノ セラピューティクス ゲーエムベーハー オリゴマー粒子試薬およびその使用方法
FI3652606T3 (fi) * 2017-07-12 2023-03-16 Nouscom Ag Jaettuihin tuumorineoantigeeneihin perustuva yleisrokote epästabiilien mikrosatelliitti (msi) -syöpien ennaltaehkäisyyn ja hoitoon
AU2018384824B2 (en) * 2017-12-13 2022-08-04 Inovio Pharmaceuticals, Inc. Cancer vaccines targeting LEMD1 and uses thereof
CN109932510B (zh) * 2017-12-18 2022-07-12 天津云检医学检验所有限公司 一种宫颈癌生物标志物及其检测试剂盒
US12516099B2 (en) 2018-08-09 2026-01-06 Juno Therapeutics, Inc. Processes for generating engineered cells and compositions thereof
SG11202104355SA (en) 2018-10-31 2021-05-28 Juno Therapeutics Gmbh Methods for selection and stimulation of cells and apparatus for same
CN112142824B (zh) * 2019-06-27 2022-03-11 深圳市东贵博康生化科技有限公司 具有诱导细胞毒性t淋巴细胞能力的多肽及其应用
WO2021060343A1 (ja) * 2019-09-24 2021-04-01 オンコセラピー・サイエンス株式会社 Urlc10由来ペプチドまたはdepdc1由来ペプチドを認識するヒトt細胞が発現するt細胞受容体
ES3001611T3 (en) * 2020-10-15 2025-03-05 Myneo Nv Method, system and computer program product for determining peptide immunogenicity

Family Cites Families (41)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4722848A (en) 1982-12-08 1988-02-02 Health Research, Incorporated Method for immunizing animals with synthetically modified vaccinia virus
US5703055A (en) 1989-03-21 1997-12-30 Wisconsin Alumni Research Foundation Generation of antibodies through lipid mediated DNA delivery
ZA926441B (en) 1991-08-26 1993-06-07 Cytel Corp HLA-restricted hepatitis B virus CTL epitopes.
EP0534615B1 (en) 1991-08-26 2001-01-03 Epimmune Inc. HLA-restricted hepatitis B virus CTL epitopes
CA2157900A1 (en) * 1993-03-11 1994-09-15 Angeline Douvas Therapeutic strategies for immunoinfective cluster virus infections
US5804566A (en) 1993-08-26 1998-09-08 The Regents Of The University Of California Methods and devices for immunizing a host through administration of naked polynucleotides with encode allergenic peptides
US5679647A (en) 1993-08-26 1997-10-21 The Regents Of The University Of California Methods and devices for immunizing a host against tumor-associated antigens through administration of naked polynucleotides which encode tumor-associated antigenic peptides
US5739118A (en) 1994-04-01 1998-04-14 Apollon, Inc. Compositions and methods for delivery of genetic material
US5736524A (en) 1994-11-14 1998-04-07 Merck & Co.,. Inc. Polynucleotide tuberculosis vaccine
US5922687A (en) 1995-05-04 1999-07-13 Board Of Trustees Of The Leland Stanford Junior University Intracellular delivery of nucleic acids using pressure
WO1997005900A1 (en) 1995-08-03 1997-02-20 Rijksuniversiteit Te Leiden Cell derived antigen presenting vesicles
US5853719A (en) 1996-04-30 1998-12-29 Duke University Methods for treating cancers and pathogen infections using antigen-presenting cells loaded with RNA
JP2000516090A (ja) 1996-07-26 2000-12-05 スローン―ケッタリング インスティチュート フォー キャンサー リサーチ 遺伝子的免疫化のための方法と試薬
FR2766205B1 (fr) 1997-07-16 2002-08-30 Inst Nat Sante Rech Med Nouveau procede de sensibilisation de cellules presentatrices d'antigene et nouveaux moyens pour la mise en oeuvre du procede
US7001999B1 (en) * 1998-04-15 2006-02-21 Ludwig Institute For Cancer Research Tumor associated nucleic acids and uses therefor
AR021849A1 (es) * 1998-09-30 2002-08-07 Corixa Corp Composiciones y metodos para la inmunoterapia especifica de wt1
US20050123938A1 (en) 1999-01-06 2005-06-09 Chondrogene Limited Method for the detection of osteoarthritis related gene transcripts in blood
US20040241726A1 (en) * 1999-01-06 2004-12-02 Chondrogene Limited Method for the detection of allergies related gene transcripts in blood
US6291663B1 (en) * 1999-03-03 2001-09-18 Board Of Trustees Of The University Of Arkansas TADG-12: a novel transmembrane serine protease overexpressed in a ovarian carcinoma
US7030215B2 (en) * 1999-03-24 2006-04-18 Sangamo Biosciences, Inc. Position dependent recognition of GNN nucleotide triplets by zinc fingers
WO2000073801A2 (en) * 1999-05-28 2000-12-07 Ludwig Institute For Cancer Research Breast, gastric and prostate cancer associated antigens and uses therefor
EP1311675B1 (en) 2000-08-22 2007-02-07 Agensys, Inc. Nucleic acid and corresponding protein named 158p1d7 useful in the treatment and detection of bladder and other cancers
WO2002031111A2 (en) 2000-10-12 2002-04-18 Hyseq, Inc. Novel nucleic acids and polypeptides
CA2425648A1 (en) * 2000-10-19 2002-04-19 Epimmune Inc. Hla class i and ii binding peptides and their uses
US7919467B2 (en) * 2000-12-04 2011-04-05 Immunotope, Inc. Cytotoxic T-lymphocyte-inducing immunogens for prevention, treatment, and diagnosis of cancer
WO2002046416A2 (en) 2000-12-04 2002-06-13 Argonex Pharmaceuticals Cytotoxic t-lymphocyte-inducing immunogens for prevention, treatment, and diagnosis of cancer
US20040142325A1 (en) * 2001-09-14 2004-07-22 Liat Mintz Methods and systems for annotating biomolecular sequences
CA2474908A1 (en) * 2002-01-31 2003-08-07 Wyeth Aggrecanase molecules
AU2003222103A1 (en) 2002-03-28 2003-10-13 Idec Pharmaceuticals Corporation Novel gene targets and ligands that bind thereto for treatment and diagnosis of colon carcinomas
US20060024692A1 (en) * 2002-09-30 2006-02-02 Oncotherapy Science, Inc. Method for diagnosing non-small cell lung cancers
TW200413725A (en) 2002-09-30 2004-08-01 Oncotherapy Science Inc Method for diagnosing non-small cell lung cancers
WO2005007090A2 (en) 2003-07-03 2005-01-27 President And Fellows Of Harvard College Inhibitors of the map kinase pathway
WO2006031221A1 (en) 2004-09-13 2006-03-23 Government Of The United States Of America, Represented By The Secretary, Department Of Health And Human Services Compositions comprising t cell receptors and methods of use thereof
CN101175862A (zh) * 2005-02-10 2008-05-07 肿瘤疗法科学股份有限公司 诊断膀胱癌的方法
JP2006302684A (ja) 2005-04-21 2006-11-02 D D K Ltd カードコネクタ
EP2295570A1 (en) * 2005-07-27 2011-03-16 Oncotherapy Science, Inc. Method of diagnosing small cell lung cancer
JP5276846B2 (ja) 2005-09-13 2013-08-28 国立大学法人三重大学 T細胞レセプターをコードする核酸が挿入されてなるベクター及び該レセプターを発現する細胞
EP1938104A2 (en) * 2005-10-17 2008-07-02 Institute for Systems Biology Tissue-and serum-derived glycoproteins and methods of their use
TWM336439U (en) * 2008-02-14 2008-07-11 Optivision Technology Inc Diffuser capable of light condensing
US8975086B2 (en) * 2008-08-28 2015-03-10 Oncotherapy Science, Inc. Method for treating or preventing bladder cancer using the DEPDC1 polypeptide
JP5564730B2 (ja) 2011-08-12 2014-08-06 オンコセラピー・サイエンス株式会社 Mphosph1ペプチドおよびそれを含むワクチン

Similar Documents

Publication Publication Date Title
JP2010506826A5 (https=)
JP2010519176A5 (https=)
RU2009118432A (ru) Пептидные вакцины против рака с экспрессией полипептидов mphosph1 или depdc1
RU2009135020A (ru) Пептидные вакцины для раков, экспрессирующих опухолеспецифические антигены
RU2009141595A (ru) Пептиды тем8 и содержащие их вакцины
RU2011110504A (ru) Эпитопные пептиды inhbb и вакцины, содержащие данные пептиды
JP2010523471A5 (https=)
JP2012500001A5 (https=)
JP2008530975A5 (https=)
JP2011524737A5 (https=)
JP2011529683A5 (https=)
JP2011522777A5 (https=)
RU2009129531A (ru) Вакцины на основе пептида foxp3
JP2014533095A5 (https=)
JP2012520659A5 (https=)
JP2019537562A5 (https=)
RU2012136464A (ru) Модифицированные пептиды melk и содержащие их вакцины
RU2014121502A (ru) Пептиды торк и содержащие их вакцины
JP2015529219A5 (https=)
JP2013517764A5 (https=)
JP2012527867A5 (https=)
RU2011120447A (ru) Эпитопные пептиды rab6kifl/kif20a и содержащие их вакцины
RU2018116851A (ru) Пептид, полученный из foxm1, и включающая его вакцина
RU2018108197A (ru) Пептид, полученный из depdc1, и содержащая его вакцина
RU2011140168A (ru) Пептиды vangl1 и содержащие их вакцины